$2.91 Billion is the total value of Eventide Asset Management's 131 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 15.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ASND | ASCENDIS PHARMA A Ssponsored adr | $199,931,000 | +87.9% | 1,698,648 | 0.0% | 6.88% | +46.0% | |
SAGE | Sell | SAGE THERAPEUTICS INC | $128,035,000 | +42.8% | 805,000 | -14.0% | 4.41% | +11.0% |
TWLO | Buy | TWILIO INCcl a | $106,832,000 | +443.8% | 827,000 | +275.9% | 3.68% | +322.5% |
ZGNX | Buy | ZOGENIX INC | $104,244,000 | +66.9% | 1,895,000 | +10.6% | 3.59% | +29.7% |
SRPT | SAREPTA THERAPEUTICS INC | $100,736,000 | +9.2% | 845,168 | 0.0% | 3.47% | -15.1% | |
TTD | THE TRADE DESK INC | $95,214,000 | +70.6% | 481,000 | 0.0% | 3.28% | +32.6% | |
W | WAYFAIR INCcl a | $76,419,000 | +64.8% | 514,777 | 0.0% | 2.63% | +28.1% | |
LOW | LOWES COS INC | $61,851,000 | +18.5% | 565,000 | 0.0% | 2.13% | -7.9% | |
ROP | Buy | ROPER TECHNOLOGIES INC | $60,529,000 | +114.3% | 177,000 | +67.0% | 2.08% | +66.5% |
MYOV | Buy | MYOVANT SCIENCES LTD | $58,936,000 | +62.9% | 2,469,021 | +12.0% | 2.03% | +26.6% |
SPLK | Sell | SPLUNK INC | $53,329,000 | -9.8% | 428,000 | -24.1% | 1.84% | -29.9% |
WCN | Buy | WASTE CONNECTIONS INC | $53,331,000 | +38.9% | 602,000 | +16.4% | 1.84% | +8.0% |
HUBS | Sell | HUBSPOT INC | $52,689,000 | +19.7% | 317,000 | -9.4% | 1.81% | -6.9% |
PANW | Sell | PALO ALTO NETWORKS INC | $51,491,000 | -9.2% | 212,000 | -29.6% | 1.77% | -29.4% |
MGTA | Buy | MAGENTA THERAPEUTICS INC | $49,712,000 | +235.6% | 3,070,239 | +15.8% | 1.71% | +160.8% |
BLUE | Buy | BLUEBIRD BIO INC | $46,355,000 | +68.3% | 294,638 | +6.1% | 1.60% | +30.8% |
AIMT | Buy | AIMMUNE THERAPEUTICS INC | $43,851,000 | +5.4% | 1,962,000 | +12.8% | 1.51% | -18.1% |
FIVN | Sell | FIVE9 INC | $42,845,000 | +9.6% | 811,000 | -9.3% | 1.47% | -14.8% |
XPO | XPO LOGISTICS INC | $42,347,000 | -5.8% | 788,000 | 0.0% | 1.46% | -26.8% | |
LRCX | LAM RESEARCH CORP | $40,635,000 | +31.5% | 227,000 | 0.0% | 1.40% | +2.2% | |
CCI | CROWN CASTLE INTL CORP NEW | $38,400,000 | +17.8% | 300,000 | 0.0% | 1.32% | -8.5% | |
LII | LENNOX INTL INC | $38,074,000 | +20.8% | 144,000 | 0.0% | 1.31% | -6.1% | |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $36,983,000 | +66.5% | 462,000 | +12.1% | 1.27% | +29.5% |
ANET | Buy | ARISTA NETWORKS INC | $36,792,000 | +153.8% | 117,000 | +70.1% | 1.27% | +97.2% |
NEP | Sell | NEXTERA ENERGY PARTNERS LP | $36,776,000 | +8.0% | 788,500 | -0.3% | 1.26% | -16.1% |
MTD | Buy | METTLER TOLEDO INTERNATIONAL | $34,704,000 | +80.5% | 48,000 | +41.2% | 1.19% | +40.3% |
COLL | COLLEGIUM PHARMACEUTICAL INC | $33,423,000 | -11.8% | 2,207,610 | 0.0% | 1.15% | -31.5% | |
ASML | ASML HOLDING N V | $32,533,000 | +20.8% | 173,000 | 0.0% | 1.12% | -6.1% | |
QURE | Sell | UNIQURE NV | $32,133,000 | +51.4% | 538,700 | -26.8% | 1.11% | +17.8% |
XYL | New | XYLEM INC | $31,379,000 | – | 397,000 | +100.0% | 1.08% | – |
KAR | KAR AUCTION SVCS INC | $31,299,000 | +7.5% | 610,000 | 0.0% | 1.08% | -16.4% | |
VMC | Buy | VULCAN MATLS CO | $30,666,000 | +182.2% | 259,000 | +135.5% | 1.06% | +119.3% |
MGA | MAGNA INTL INC | $29,881,000 | +7.1% | 613,700 | 0.0% | 1.03% | -16.8% | |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $29,542,000 | +35.6% | 2,033,144 | +3.0% | 1.02% | +5.4% |
IMMU | IMMUNOMEDICS INC | $27,125,000 | +34.6% | 1,412,000 | 0.0% | 0.93% | +4.6% | |
PAYC | PAYCOM SOFTWARE INC | $26,667,000 | +54.5% | 141,000 | 0.0% | 0.92% | +20.2% | |
STLD | STEEL DYNAMICS INC | $26,594,000 | +17.4% | 754,000 | 0.0% | 0.92% | -8.8% | |
KALV | KALVISTA PHARMACEUTICALS INC | $25,758,000 | +44.9% | 900,000 | 0.0% | 0.89% | +12.6% | |
BHVN | BIOHAVEN PHARMACTL HLDG CO L | $25,375,000 | +39.2% | 493,000 | 0.0% | 0.87% | +8.2% | |
VRNS | Sell | VARONIS SYS INC | $25,045,000 | -27.4% | 420,000 | -35.6% | 0.86% | -43.5% |
LEA | LEAR CORP | $24,971,000 | +10.5% | 184,000 | 0.0% | 0.86% | -14.2% | |
INST | Sell | INSTRUCTURE INC | $24,267,000 | -19.7% | 515,000 | -36.1% | 0.84% | -37.6% |
IPHI | INPHI CORP | $24,276,000 | +36.1% | 555,000 | 0.0% | 0.84% | +5.7% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $23,787,000 | +113.5% | 270,000 | +73.1% | 0.82% | +66.1% |
VCYT | VERACYTE INC | $23,269,000 | +98.9% | 930,000 | 0.0% | 0.80% | +54.6% | |
ALTR | Sell | ALTAIR ENGR INC | $23,117,000 | -16.2% | 628,000 | -37.2% | 0.80% | -34.9% |
ICPT | Buy | INTERCEPT PHARMACEUTICALS IN | $22,931,000 | +35.4% | 205,000 | +22.0% | 0.79% | +5.2% |
MYOK | Buy | MYOKARDIA INC | $22,720,000 | +54.0% | 437,000 | +44.7% | 0.78% | +19.8% |
PEGI | Sell | PATTERN ENERGY GROUP INCcl a | $22,660,000 | +16.5% | 1,030,000 | -1.4% | 0.78% | -9.4% |
CTAS | Buy | CINTAS CORP | $22,434,000 | +167.1% | 111,000 | +122.0% | 0.77% | +107.5% |
FOLD | Buy | AMICUS THERAPEUTICS INC | $21,964,000 | +71.6% | 1,615,000 | +20.9% | 0.76% | +33.3% |
APTV | Buy | APTIV PLC | $21,860,000 | +29.4% | 275,000 | +0.2% | 0.75% | +0.5% |
STML | Buy | STEMLINE THERAPEUTICS INC | $20,682,000 | +100.4% | 1,609,523 | +48.2% | 0.71% | +55.8% |
AVRO | AVROBIO INC | $20,482,000 | +37.5% | 928,891 | 0.0% | 0.70% | +6.8% | |
GLPG | Buy | GALAPAGOS NVspon adr | $20,376,000 | +455.2% | 173,000 | +332.5% | 0.70% | +332.7% |
TLND | TALEND S Aads | $19,623,000 | +36.4% | 388,033 | 0.0% | 0.68% | +6.0% | |
BOLD | Buy | AUDENTES THERAPEUTICS INC | $19,471,000 | +232.1% | 499,000 | +81.5% | 0.67% | +157.7% |
GBT | GLOBAL BLOOD THERAPEUTICS IN | $19,425,000 | +28.9% | 367,000 | 0.0% | 0.67% | +0.1% | |
PFPT | PROOFPOINT INC | $19,186,000 | +44.9% | 158,000 | 0.0% | 0.66% | +12.6% | |
ARGX | Sell | ARGENX SEsponsored adr | $19,101,000 | -21.7% | 153,000 | -39.8% | 0.66% | -39.2% |
HASI | Sell | HANNON ARMSTRONG SUST INFR C | $17,769,000 | +33.6% | 693,000 | -0.7% | 0.61% | +3.7% |
WBC | Sell | WABCO HLDGS INC | $17,665,000 | -35.6% | 134,000 | -47.6% | 0.61% | -50.0% |
VKTX | VIKING THERAPEUTICS INC | $17,465,000 | +29.9% | 1,757,000 | 0.0% | 0.60% | +1.0% | |
AY | Sell | ATLANTICA YIELD PLC | $16,677,000 | -1.7% | 857,000 | -1.0% | 0.57% | -23.6% |
GWPH | Buy | GW PHARMACEUTICALS PLCads | $15,678,000 | +153.5% | 93,006 | +46.5% | 0.54% | +96.7% |
STKL | SUNOPTA INC | $14,880,000 | -10.6% | 4,300,540 | 0.0% | 0.51% | -30.5% | |
STRO | SUTRO BIOPHARMA INC | $13,770,000 | +26.3% | 1,244,895 | 0.0% | 0.47% | -1.9% | |
MIC | Sell | MACQUARIE INFRASTRUCTURE COR | $13,417,000 | -31.5% | 325,500 | -39.3% | 0.46% | -46.8% |
RCKT | ROCKET PHARMACEUTICALS INC | $12,429,000 | +18.4% | 708,600 | 0.0% | 0.43% | -8.0% | |
OKTA | New | OKTA INCcl a | $12,410,000 | – | 150,000 | +100.0% | 0.43% | – |
EXAS | Buy | EXACT SCIENCES CORP | $12,127,000 | +46.7% | 140,000 | +6.9% | 0.42% | +13.9% |
IFRX | INFLARX NV | $10,392,000 | +3.9% | 275,000 | 0.0% | 0.36% | -19.2% | |
ARQL | Buy | ARQULE INC | $10,059,000 | +240.6% | 2,100,000 | +97.0% | 0.35% | +164.1% |
MDCO | MEDICINES CO | $9,363,000 | +46.0% | 335,000 | 0.0% | 0.32% | +13.4% | |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $8,740,000 | +136.5% | 384,000 | +211.6% | 0.30% | +83.5% |
MGNX | New | MACROGENICS INC | $8,720,000 | – | 485,000 | +100.0% | 0.30% | – |
ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $8,280,000 | +1.1% | 800,000 | 0.0% | 0.28% | -21.5% | |
EXR | EXTRA SPACE STORAGE INC | $8,153,000 | +12.6% | 80,000 | 0.0% | 0.28% | -12.2% | |
THOR | SYNTHORX INC | $8,148,000 | +17.2% | 400,000 | 0.0% | 0.28% | -9.1% | |
RARX | Sell | RA PHARMACEUTICALS INC | $8,062,000 | +14.2% | 359,900 | -7.2% | 0.28% | -11.5% |
SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $7,248,000 | +669.4% | 5,965,455 | +163.3% | 0.25% | +492.9% |
UROV | UROVANT SCIENCES LTD | $6,723,000 | +52.5% | 669,000 | 0.0% | 0.23% | +18.5% | |
WVE | WAVE LIFE SCIENCES LTD | $6,620,000 | -7.6% | 170,400 | 0.0% | 0.23% | -28.1% | |
RGEN | REPLIGEN CORP | $6,499,000 | +12.0% | 110,000 | 0.0% | 0.22% | -12.8% | |
XNCR | XENCOR INC | $6,305,000 | -14.1% | 203,000 | 0.0% | 0.22% | -33.2% | |
XENE | Buy | XENON PHARMACEUTICALS INC | $6,306,000 | +135.5% | 620,691 | +46.2% | 0.22% | +82.4% |
XLRN | ACCELERON PHARMA INC | $6,003,000 | +6.9% | 128,900 | 0.0% | 0.21% | -16.9% | |
ADVM | ADVERUM BIOTECHNOLOGIES INC | $6,008,000 | +66.3% | 1,146,580 | 0.0% | 0.21% | +29.4% | |
ETTX | ENTASIS THERAPEUTICS HLDGS I | $5,776,000 | +65.9% | 879,541 | 0.0% | 0.20% | +29.2% | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $5,761,000 | -35.7% | 319,000 | 0.0% | 0.20% | -50.1% | |
ORTX | ORCHARD THERAPEUTICS PLCads | $4,828,000 | +13.7% | 270,000 | 0.0% | 0.17% | -11.7% | |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $4,783,000 | -87.1% | 26,000 | -88.3% | 0.16% | -89.9% |
CBIO | Buy | CATALYST BIOSCIENCES INC | $3,754,000 | +93.4% | 462,852 | +88.2% | 0.13% | +50.0% |
CERC | New | CERECOR INC | $3,504,000 | – | 600,000 | +100.0% | 0.12% | – |
FENC | FENNEC PHARMACEUTICALS INC | $3,492,000 | -24.0% | 720,000 | 0.0% | 0.12% | -40.9% | |
VBIV | VBI VACCINES INC | $3,460,000 | +16.9% | 1,850,000 | 0.0% | 0.12% | -9.2% | |
BEP | Sell | BROOKFIELD RENEWABLE PARTNERpartnership unit | $2,508,000 | -6.0% | 78,500 | -23.8% | 0.09% | -27.1% |
ABB | Buy | ABB LTDsponsored adr | $2,434,000 | +0.8% | 129,000 | +1.6% | 0.08% | -21.5% |
FHB | FIRST HAWAIIAN INC | $2,449,000 | +15.7% | 94,000 | 0.0% | 0.08% | -10.6% | |
TERP | Sell | TERRAFORM PWR INC | $2,405,000 | +19.1% | 175,000 | -2.8% | 0.08% | -6.7% |
HMC | HONDA MOTOR LTD | $2,160,000 | +2.7% | 79,500 | 0.0% | 0.07% | -20.4% | |
TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $2,028,000 | -3.6% | 49,500 | -13.2% | 0.07% | -24.7% |
ETN | EATON CORP PLC | $1,941,000 | +17.3% | 24,100 | 0.0% | 0.07% | -8.2% | |
HANNON ARMSTRONG SUST INFR Cnote 4.125% 9/0 | $1,921,000 | +11.4% | 1,894,000 | 0.0% | 0.07% | -13.2% | ||
MLHR | Sell | MILLER HERMAN INC | $1,794,000 | +13.0% | 51,000 | -2.9% | 0.06% | -11.4% |
BDN | Sell | BRANDYWINE RLTY TRsh ben int new | $1,753,000 | +18.9% | 110,500 | -3.5% | 0.06% | -7.7% |
EPIX | Buy | ESSA PHARMA INC | $1,653,000 | +63.3% | 481,971 | +0.0% | 0.06% | +26.7% |
JCI | Sell | JOHNSON CTLS INTL PLC | $1,607,000 | -7.4% | 43,500 | -25.6% | 0.06% | -28.6% |
CCIPRA | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $1,605,000 | +12.6% | 1,355 | 0.0% | 0.06% | -12.7% | |
BG | BUNGE LIMITED | $1,523,000 | -0.7% | 28,700 | 0.0% | 0.05% | -23.5% | |
DERMIRA INCnote 3.000% 5/1 | $1,065,000 | +14.5% | 1,200,000 | 0.0% | 0.04% | -9.8% | ||
ARE | Sell | ALEXANDRIA REAL ESTATE EQ IN | $1,069,000 | -7.2% | 7,500 | -25.0% | 0.04% | -27.5% |
APU | AMERIGAS PARTNERS L Punit l p int | $1,019,000 | +22.0% | 33,000 | 0.0% | 0.04% | -5.4% | |
PLD | Sell | PROLOGIS INC | $935,000 | +6.1% | 13,000 | -13.3% | 0.03% | -17.9% |
ERIC | Sell | ERICSSONadr b sek 10 | $932,000 | -4.5% | 101,500 | -7.7% | 0.03% | -25.6% |
GPMT | GRANITE PT MTG TR INC | $910,000 | +3.1% | 49,000 | 0.0% | 0.03% | -20.5% | |
NOK | Buy | NOKIA CORPsponsored adr | $875,000 | +499.3% | 153,000 | +512.0% | 0.03% | +400.0% |
LXP | LEXINGTON REALTY TRUST | $725,000 | +10.4% | 80,000 | 0.0% | 0.02% | -13.8% | |
CVA | Sell | COVANTA HLDG CORP | $727,000 | -32.3% | 42,000 | -47.5% | 0.02% | -47.9% |
IR | New | INGERSOLL-RAND PLC | $648,000 | – | 6,000 | +100.0% | 0.02% | – |
LPT | Sell | LIBERTY PPTY TRsh ben int | $508,000 | -21.7% | 10,500 | -32.3% | 0.02% | -41.4% |
PSA | PUBLIC STORAGE | $436,000 | +7.7% | 2,000 | 0.0% | 0.02% | -16.7% | |
MEDICINES COnote 2.750% 7/1 | $423,000 | +11.6% | 500,000 | 0.0% | 0.02% | -11.8% | ||
VTR | Sell | VENTAS INC | $383,000 | -23.1% | 6,000 | -29.4% | 0.01% | -40.9% |
ACORDA THERAPEUTICS INCnote 1.750% 6/1 | $355,000 | +6.6% | 400,000 | 0.0% | 0.01% | -20.0% | ||
CIG | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $232,000 | +0.4% | 65,000 | 0.0% | 0.01% | -20.0% | |
New | HERCULES CAPITAL INCdbcv 4.375% 2/0 | $196,000 | – | 200,000 | +100.0% | 0.01% | – | |
NXPI | New | NXP SEMICONDUCTORS N V | $177,000 | – | 2,000 | +100.0% | 0.01% | – |
WDC | New | WESTERN DIGITAL CORP | $144,000 | – | 3,000 | +100.0% | 0.01% | – |
New | PATTERN ENERGY GROUP INCnote 4.000% 7/1 | $101,000 | – | 100,000 | +100.0% | 0.00% | – | |
CWEN | Sell | CLEARWAY ENERGY INCcl c | $91,000 | -67.0% | 6,000 | -62.5% | 0.00% | -75.0% |
Exit | HERCULES CAPITAL INCdbcv 4.375% 2/0 | $0 | – | -200,000 | -100.0% | -0.01% | – | |
WELL | Exit | WELLTOWER INC | $0 | – | -7,500 | -100.0% | -0.02% | – |
DERM | Exit | DERMIRA INC | $0 | – | -334,000 | -100.0% | -0.11% | – |
GTTN | Exit | GTT COMMUNICATIONS INC | $0 | – | -112,991 | -100.0% | -0.12% | – |
PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -113,000 | -100.0% | -0.17% | – |
VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -436,000 | -100.0% | -0.18% | – |
DOOR | Exit | MASONITE INTL CORP NEW | $0 | – | -170,000 | -100.0% | -0.34% | – |
BCRX | Exit | BIOCRYST PHARMACEUTICALS | $0 | – | -1,047,000 | -100.0% | -0.37% | – |
WTRH | Exit | WAITR HLDGS INC | $0 | – | -876,000 | -100.0% | -0.43% | – |
CRUS | Exit | CIRRUS LOGIC INC | $0 | – | -370,000 | -100.0% | -0.54% | – |
LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -274,000 | -100.0% | -1.70% | – |
SEND | Exit | SENDGRID INC | $0 | – | -1,793,000 | -100.0% | -3.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.